Capital International Inc. CA Has $65.42 Million Stock Position in Danaher Corporation $DHR

Capital International Inc. CA grew its position in Danaher Corporation (NYSE:DHR) by 4.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 285,758 shares of the conglomerate’s stock after buying an additional 13,398 shares during the period. Capital International Inc. CA’s holdings in Danaher were worth $65,416,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in DHR. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher during the second quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Danaher during the third quarter worth $27,000. Finally, Financial Life Planners acquired a new stake in shares of Danaher during the third quarter worth $32,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 1.2%

NYSE:DHR opened at $184.45 on Friday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a market cap of $130.55 billion, a price-to-earnings ratio of 35.68, a PEG ratio of 2.46 and a beta of 0.81. The stock has a 50-day moving average price of $181.29 and a two-hundred day moving average price of $206.19.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the previous year, the company posted $1.88 earnings per share. As a group, equities analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Evercore lifted their price objective on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a research note on Friday, April 17th. Barclays decreased their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Finally, Guggenheim decreased their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $235.14.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.